the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. According to IQVIA, US sales of Foscarnet
Mucocutaneous Acyclovir Resistant HSV Infections FOSCAVIR is indicated for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. SAFETY AND EFFICACY OF FOSCAVIR HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER HSV INFECTIONS (e.g, RETINITIS, ENCEPHALITIS); CONGENITAL OR NEONATAL HSV DISEASE; OR HSV IN
Foscarnet sodium injection is indicated for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.
Treatment for acyclovir-resistant genital herpes: Foscarnet (40 The following are regimens for acyclovir‐resistant HSV in adult HSV‐
Defining the global prevalence of acyclovir resistance in HSV infections is hampered by the high variability in methodology, patient selection, study design, and treatment history among the studies. Acyclovir resistant HSV is infrequent in the immunocompetent population (generally below 1%), irrespective of treatment history.
by CD Enescu 2024 Cited by 8Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir treatment of choice in acyclovir-resistant HSV. 2.
by CD Enescu 2024 Cited by 8Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir treatment of choice in acyclovir-resistant HSV. Their nephrotoxic side
In addition, ganciclovir should not be used for acyclovir-resistant HSV infections, because of cross-resistance. Ganciclovir and acyclovir share the same
General Information ; Lab Name: HSV Acyclovir Drug Resistance ; Lab Code: HSVDR ; Epic Ordering: HSV Acyclovir Drug Resistance ; Description. HSV Type 1 and HSV
Comments